107 related articles for article (PubMed ID: 26381879)
1. Effect of Chondroitin Sulphate on Pro-Inflammatory Mediators and Disease Activity in Patients with Inflammatory Bowel Disease.
Linares PM; Chaparro M; Algaba A; Román M; Moreno Arza I; Abad Santos F; Ochoa D; Guerra I; Bermejo F; Gisbert JP
Digestion; 2015; 92(4):203-10. PubMed ID: 26381879
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-18 and its binding protein in patients with inflammatory bowel disease during remission and exacerbation.
Naftali T; Novick D; Gabay G; Rubinstein M; Novis B
Isr Med Assoc J; 2007 Jul; 9(7):504-8. PubMed ID: 17710779
[TBL] [Abstract][Full Text] [Related]
4. Classifying Back Pain and Peripheral Joint Complaints in Inflammatory Bowel Disease Patients: A Prospective Longitudinal Follow-up Study.
van Erp SJ; Brakenhoff LK; van Gaalen FA; van den Berg R; Fidder HH; Verspaget HW; Huizinga TW; Veenendaal RA; Wolterbeek R; van der Heijde D; van der Meulen-de Jong AE; Hommes DW
J Crohns Colitis; 2016 Feb; 10(2):166-75. PubMed ID: 26512134
[TBL] [Abstract][Full Text] [Related]
5. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
6. Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease.
Algaba A; Linares PM; Fernández-Contreras ME; Ordoñez A; Trápaga J; Guerra I; Chaparro M; de la Poza G; Gisbert JP; Bermejo F
J Crohns Colitis; 2013 Dec; 7(11):e569-79. PubMed ID: 23642997
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis.
Danese S; Sans M; de la Motte C; Graziani C; West G; Phillips MH; Pola R; Rutella S; Willis J; Gasbarrini A; Fiocchi C
Gastroenterology; 2006 Jun; 130(7):2060-73. PubMed ID: 16762629
[TBL] [Abstract][Full Text] [Related]
8. Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate.
Lambert C; Mathy-Hartert M; Dubuc JE; Montell E; Vergés J; Munaut C; Noël A; Henrotin Y
Arthritis Res Ther; 2012 Mar; 14(2):R58. PubMed ID: 22409996
[TBL] [Abstract][Full Text] [Related]
9. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
Straub RH; Vogl D; Gross V; Lang B; Schölmerich J; Andus T
Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis.
Morreale P; Manopulo R; Galati M; Boccanera L; Saponati G; Bocchi L
J Rheumatol; 1996 Aug; 23(8):1385-91. PubMed ID: 8856618
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-4 inhibits the increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease.
Griga T; Hebler U; Voigt E; Tromm A; May B
Hepatogastroenterology; 2000; 47(36):1604-7. PubMed ID: 11149012
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring of infliximab in inflammatory bowel disease patients in a teaching hospital setting: results of a prospective cohort study.
Warman A; Straathof JW; Derijks LJ
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):242-8. PubMed ID: 25569569
[TBL] [Abstract][Full Text] [Related]
13. Back/joint pain, illness perceptions and coping are important predictors of quality of life and work productivity in patients with inflammatory bowel disease: a 12-month longitudinal study.
van der Have M; Brakenhoff LK; van Erp SJ; Kaptein AA; Leenders M; Scharloo M; Veenendaal RA; van der Heijde DM; van der Meulen-de Jong AE; Hommes DW; Fidder HH
J Crohns Colitis; 2015 Mar; 9(3):276-83. PubMed ID: 25547976
[TBL] [Abstract][Full Text] [Related]
14. Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease.
Katsanos KH; Tsatsoulis A; Christodoulou D; Challa A; Katsaraki A; Tsianos EV
Growth Horm IGF Res; 2001 Dec; 11(6):364-7. PubMed ID: 11914023
[TBL] [Abstract][Full Text] [Related]
15. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
Ciećko-Michalska I; Fedak D; Mach T
Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
[TBL] [Abstract][Full Text] [Related]
16. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
17. Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease.
Fägerstam JP; Whiss PA; Ström M; Andersson RG
Inflamm Res; 2000 Sep; 49(9):466-72. PubMed ID: 11071121
[TBL] [Abstract][Full Text] [Related]
18. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Sfiridaki A; Mouzas IA; Maladaki A; Kapsoritakis A; Roussomoustakaki M; Kouroumalis EA; Manousos ON
Am J Gastroenterol; 2000 Jan; 95(1):190-4. PubMed ID: 10638581
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory bowel disease in children--clinical, endoscopic, radiologic and histopathologic investigation.
Seo JK; Yeon KM; Chi JG
J Korean Med Sci; 1992 Sep; 7(3):221-35. PubMed ID: 1285921
[TBL] [Abstract][Full Text] [Related]
20. Relationship between serum interleukin-17 level and inflammatory bowel disease.
Liu QL; Huang L; Zhao QJ; Li Q; He Z
J Biol Regul Homeost Agents; 2016; 30(1):181-8. PubMed ID: 27049090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
